Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

Richard O' Riordan wants the drug Vabysmo to be more widely used to treat wet AMD A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug ...

Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to ...

A Guernsey resident believes "people's enjoyment in life" is being sacrificed for the financial cost of using a drug that can treat wet age-related macular degeneration (AMD). Richard O' Riordan, 82, ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

Groundbreaking study finds way to ‘reboot’ eye and restore impaired vision - Findings may lead to new treatment for ‘lazy eye ...

Under the merger terms, Eli Lilly will launch a tender offer to acquire all outstanding Adverum shares for up to $12.47 per share, consisting of $3.56 in cash at closing and a non-transferable ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Oct 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Friday it would acquire gene therapy developer Adverum Biotechnologies (ADVM.O), opens new tab in a deal valued at up to $261.7 million, ...

Racing Post+ tipping is our top-tier betting advice service, starring our biggest and best experts. This and lots more exclusive insight is published every night on racingpost.com from 6pm. Racing ...